Plasma Triglycerides and Red Cell Ion Transport Alterations in Genetically Hypertensive Rats

Hypertension

Volumn 30, Issue 3, 1997, Pages 636-640

  Zicha, Josef ^a   Dobesova, Zdenka ^a   Kunes, Jaroslav ^a  

^a INSTITUTE OF PHYSIOLOGY   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); BUMETANIDE; CHOLESTEROL; LIPID; POTASSIUM ION; SODIUM ION; TRIACYLGLYCEROL; URIC ACID;

ANIMAL MODEL; BLOOD PRESSURE; CHOLESTEROL BLOOD LEVEL; CONFERENCE PAPER; CONTROLLED STUDY; ERYTHROCYTE; HYPERTENSION; MALE; NONHUMAN; POTASSIUM TRANSPORT; PRIORITY JOURNAL; RAT; SODIUM TRANSPORT; TRIACYLGLYCEROL BLOOD LEVEL; VISCOSITY;

ANIMALS; CARRIER PROTEINS; ERYTHROCYTES; HYPERTENSION; ION TRANSPORT; MALE; NA(+)-K(+)-EXCHANGING ATPASE; RATS; SODIUM-POTASSIUM-CHLORIDE SYMPORTERS; TRIGLYCERIDES;

EID: 0343487872     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/01.HYP.30.3.636     Document Type: Article

References (44)

1. Corrocher R, Steinmayr M, Ruzzenente O, Brugnara C, Bertinato L, Mazzi M, Furri C, Bonfanti F, De Sandre G. Elevation of red cell sodium-lithium countertransport in hyperlipidemias. Life Sci. 1985;36:649-655.
2. Carr SJ, Thomas TH, Laker MF, Wilkinson R. Elevated sodium-lithium countertransport: a familial marker of hyperlipidaemia and hypertension? J Hypertens. 1990;8:139-146.
3. Strazzullo P,. Cappuccio FP, Trevisan M, Siani A, Barba G, Ragone E, Pagano E, Mancini M. The relationship of erythrocyte sodium-lithium countertransport to blood pressure and metabolic abnormalities in a sample of untreated middle-aged male workers. J Hypertens. 1993;11:815-822.
4. Carr SJ, Thomas TH, Laker MF, Wilkinson R. Lipid lowering therapy leads to a reduction in sodium-lithium countertransport activity. Atherosclerosis. 1991;87:103-108.
5. Rutherford PA, Thomas TH, Laker MF, Wilkinson R. Plasma lipids affect maximum velocity not sodium affinity of human sodium-lithium countertransport: distinction from essential hypertension. Eur J Clin Invest. 1992;22:719-724.
6. Corrocher R, Ferrari S, Bassi A, Guarini P, Bertinato L, Olivieri O, Licia GM, Ruzzenente O, Brugnara C, De Sandre G. Membrane polyunsaturated fatty acids and lithium-sodium countertransport in human erythrocytes. Life Sci. 1987;41:1171-1178.
7. + binding and phospholipid composition in erythrocyte membranes of white hypertensive and normotensive individuals: a nuclear magnetic resonance investigation. Hypertension. 1996;27:456-464.
8. Pagnan A, Corrocher R, Ambrosio GB, Ferrari S, Guarini P, Piccolo D, Opportuno A, Bassi A, Olivieri O, Baggio G. Effects of an olive-oil-rich diet on erythrocyte membrane lipid composition and cation transport systems. Clin Sci. 1989;76:87-93.
9. Corrocher R, Pagnan A, Ambrosio GB, Ferrari S, Olivieri O, Guarini P, Bassi A, Piccolo D, Gandini A, Girelli D. Effects induced by olive oil-rich diet on erythrocytes, membrane lipids and sodium-potassium transports in postmenopausal hypertensive women. J Endocrinol Invest. 1992;15:369-376.
10. Lijnen P, Fagard R, Staessen J, Thijs L, Amery A. Erythrocyte membrane lipids and cationic transport systems in men. J Hypertens. 1992;10:1205-1211.
11. + countertransport in essential hypertension: correlation with membrane lipid levels. J Hypertens. 1996;14:969-973.
12. Muriana FJ, Villar J, Ruiz-Gutierrez V. Erythrocyte membrane cholesterol distribution in patients with untreated essential hypertension: correlation with sodium-lithium countertransport. J Hypertens. 1996;14:443-446.
13. + countertransport: in vivo and in vitro evidence. J Membr Biol. 1993;133:99-106.
14. Engelmann B, Duhm J, Schonthier UM, Streich S. Relations of sodium-lithium countertransport kinetics to plasma and red cell membrane phospholipids in hyperlipidemia. Atherosclerosis. 1993;99:151-163.
15. Dowd A, Thomas TH, Wilkinson R. Increased human erythrocyte sodium-lithium countertransport in hyperlipidaemic patients may indicate increased membrane lipid fluidity. Eur J Clin Invest. 1993;23:102-107.
16. Carr SJ, Sikand K, Moore D, Norman RI. Altered membrane microviscosity in essential hypertension: relationship with family history of hypertension and sodium-lithium countertransport activity. J Hypertens. 1995;13:139-146.
17. Le Quan Sang KH, Mazeaud M, Astarie C, Duranthon V, Driss F, Devynck MA. Plasma lipids and platelet membrane fluidity in essential hypertension. Thromb Haemost. 1993;69:70-76.
18. + -ATPase and membrane and serum lipid profiles: as related to alcohol, body mass index and blood pressure. Clin Exp Hypertens. 1994;16:741-759.
19. Malle E, Gries A, Kostner GM, Pfeiffer K, Nimpf J, Hermetter A. Is there any correlation between platelet aggregation, plasma lipoproteins, apoproteins and membrane fluidity of human blood platelets? Thromb Res. 1989;53:181-190.
20. Miller MA, Sagnella GA, Markandu ND, MacGregor GA. Comparison of calcium, magnesium-ATPase activity and membrane fluidity in patients with essential hypertension and in normotensive controls. J Hypertens. 1994;12:929-938.
21. + cotransport in essential hypertension, primary hyperaldosteronism, and hypokalemia. Scand J Clin Lab Invest. 1986;46(suppl 180):82-95.
22. Hunt SC, Williams RR, Smith JB, Ash KO. Associations of three erythrocyte cation transport systems with plasma lipids in Utah subjects. Hypertension. 1986;8:30-36.
23. Winocour PH, Thomas TH, Brown L, Laker MF, Wilkinson R, Alberti KG. Serum triglyceride and insulin levels are associated with erythrocyte sodium-lithium counter-transport activity in normoglycaemic individuals. Clin Chim Acta. 1992;208:193-203.
24. Hespel P, Lijnen P, Fagard R, M'Buyamba-Kabangu JR, Van Hoof R, Lissens W, Rosseneu M, Amery A. Changes in erythrocyte sodium and plasma lipids associated with physical training. J Hypertens. 1988;6:159-166.
25. Hajem S, Moreau T, Hannaert P, Lellouch J, Orssaud G, Huel G, Claude JR, Garay RP. Erythrocyte cation transport systems and plasma lipids in a general male population. J Hypertens. 1990;8:891-896.
26. Zicha J. Red cell ion transport abnormalities in experimental hypertension. Fundam Clin Pharmacol. 1993;7:129-141.
27. De Mendonca M, Knorr A, Grichois ML, Ben-Ishay D, Garay RP, Meyer P. Erythrocytic sodium ion transport systems in primary and secondary hypertension of the rat. Kidney Int. 1982;21(suppl 11):S69-S75.
28. Ferrari P, Ferrandi M, Torielli L, Canessa M, Bianchi G. Relationship between erythrocyte volume and sodium transport in the Milan hypertensive rat and age-dependent changes. J Hypertens. 1987;5:199-206.
29. + transport in red blood cells of Dahl rats: effects of age and salt. Hypertension. 1990;15:612-627.
30. + transport in Prague hypertensive rats. Clin Exp Hypertens. 1990;12:1203-1222.
31. Vincent M, Sacquet J, Sassard J. The Lyon strains of hypertensive, normotensive and low-blood-pressure rats. In: De Jong W, ed. Handbook of Hypertension, IV: Experimental and Genetic Models of Hypertension. Amsterdam, Netherlands: Elsevier; 1984:314-327.
32. Sassolas A, Vincent M, Benzoni D, Sassard J. Plasma lipids in genetically hypertensive rats of the Lyon strain. J Cardiovasc Pharmacol. 1981;3:1008-1014.
33. Vrana A, Kazdova L. The hereditary hypertriglyceridemic nonobese rat: an experimental model of human hypertriglyceridemia. Transplant Proc. 1990;22:2579.
34. Stolba P, Dobesova Z, Husek P, Opltova H, Zicha J, Vrana A, Kunes J. The hypertriglyceridemic rat as a genetic model of hypertension and diabetes. Life Sci. 1992;51:733-740.
35. Bin Talib HK, Zicha J. Red cell sodium in DOCA-salt hypertension: a Brattleboro study. Life Sci. 1992;50:1021-1030.
36. Bin Talib HK, Dobesova Z, Klir P, Kren V, Kunes J, Pravenec M, Zicha J. Association of red blood cell sodium leak with blood pressure in recombinant inbred strains. Hypertension. 1992;20:575-582.
37. Testa I, Rabini RA, Fumelli P, Bertoli E, Mazzanti L. Abnormal membrane fluidity and acetylcholinesterase activity in erythrocytes from insulin-dependent diabetic patients. J Clin Endocrinol Metab. 1988;67:1129-1133.
38. Lijnen P, Petrov V. Cholesterol modulation of transmembrane cation transport systems in human erythrocytes. Biochem Mol Med. 1995;56:52-62.
39. Shinitzky M. Membrane fluidity and cellular functions. In: Shinitzky M, ed. Physiology of Membrane Fluidity. Boca Raton, Fla: CRC Press; 1984:1-51.
40. Le Quan Sang KH, Kunes J, Zicha J, Vincent M, Sassard J, Devynck MA. Platelet and erythrocyte membrane microviscosity in Lyon hypertensive rats. Am J Hypertens. 1994;7:276-281.
41. Zicha J, Kunes J, Devynck MA. Hereditary hypertriglyceridemic rats: triglyceride-dependent cell membrane parameters. Hypertension. 1996;28:688. Abstract.
42. Zicha J, Kunes J, David-Dufilho M, Pernollet MG, Devynck MA. Cell calcium handling and intracellular pH regulation in hereditary hypertriglyceridemic rats: reduced platelet response to thrombin stimulation. Life Sci. 1996;59:803-813.
43. Wiley JS, Cooper RA. Inhibition of cation cotransport by cholesterol enrichment of human red cell membranes. Biochim Biophys Acta. 1975;413:425-431.
44. Lijnen P, Fenyvesi A, Bex M, Bouillon R, Amery A. Erythrocyte cation transport systems and membrane lipids in insulin-dependent diabetes. Am J Hypertens. 1993;6:763-770.